Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia

Piperacillin therapy for serious bacterial infections

Drew J. Winston, Wendy Murphy, Lowell S. Young et al. · The American Journal of Medicine · 1980 · 120 citations

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12

Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases

Ludwig Gutmann, M Kitzis, Shigeru Yamabe et al. · Antimicrobial Agents and Chemotherapy · 1986 · 113 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

N. A. KUCK, N V Jacobus, Peter J. Petersen et al. · Antimicrobial Agents and Chemotherapy · 1989 · 94 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains.

Ronald N. Jones, Michael A. Pfaller, Peter Fuchs et al. · PubMed · 1990 · 56 citations

Life Sciences, Infectious Diseases, Microbiology +13

Survey of Bacteroides fragilis group susceptibility patterns in Canada

Anne–Marie Bourgault, F Lamothe, D. J. Hoban et al. · Antimicrobial Agents and Chemotherapy · 1992 · 48 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15